Jara, M., Aquilina, T., Aupperle, P., & Rabinowicz, A. L. (2015). Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States. Drug Healthc Patient Saf.
Chicago Stili AlıntıJara, Michele, Thomas Aquilina, Peter Aupperle, ve Adrian L. Rabinowicz. "Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis: 5-year Postmarketing Experience in the United States." Drug Healthc Patient Saf 2015.
MLA AlıntıJara, Michele, Thomas Aquilina, Peter Aupperle, ve Adrian L. Rabinowicz. "Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis: 5-year Postmarketing Experience in the United States." Drug Healthc Patient Saf 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..